Work

Erratum: The promise of neuroprotective agents in Parkinson's disease

Year: 2013
Type: erratum
Abstract: After our article was published online, it was brought to our attention that in Table 1 we incorrectly stated the findings from a study testing the safety of Isradipine (Simuni et al., 2010). We have thus changed the text in the table to reflect the results that Isradipine has been shown to be safe and well-tolerated in PD patients.
Language: English
Subfield: Neurology
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W2139855996
Cites: 1
Cited by: 3
Related to: 10